Life AI Net
Accueil
Archives
Calculateurs
Annuaire
Newsletter
Hot
Connexion
Français
English
简体中文
Deutsch
Français
Español
日本語
한국어
العربية
Auto
Accueil
Archives
Calculateurs
Annuaire
Newsletter
English
简体中文
Deutsch
Français
Español
日本語
한국어
العربية
Auto
Connexion
Accueil
Archives
Calculateurs
Annuaire
More
Live
Thermo Fisher
TMO Thermo Fisher Scientific Inc falls 2.95 percent post Q4 2025 earnings despite narrow EPS beat and 3.9 percent year-over-year revenue growth. - Investment Community Signals - UBND thành phố Hải Phòng
FierceBiotech
Lilly reneges on remainder of Rigel deal in another blow for RIPK1 inhibitors
Thermo Fisher
Thermo Fisher (TMO) Q4 2024 Earnings Transcript - AOL.com
Waters
WAT (Waters Corporation) rises 1.06 percent after Q4 2025 results, as 7 percent revenue growth offsets minor EPS miss. - Earnings Risk - Cổng thông tin điện tử Tỉnh Sơn La
FierceBiotech
McKesson swaps minority stake in surgical unit to Apollo Funds for $1.25B
FierceBiotech
AcuityMD raises $80M to help bolster AI in the medtech industry
FierceBiotech
AACR: NCI leader Letai battles ‘misinformation’ to assure anxious researchers that ‘funding is strong’
FierceBiotech
Merck goes with Google for AI push, striking enterprise partnership worth up to $1B
BioWorld
Appointments and advancements for April 22, 2026
BioWorld
Financings for April 22, 2026
BioWorld
In the clinic for April 22, 2026
BioWorld
Other news to note for April 22, 2026
Thermo Fisher
TMO Thermo Fisher Scientific Inc falls 2.95 percent post Q4 2025 earnings despite narrow EPS beat and 3.9 percent year-over-year revenue growth. - Investment Community Signals - UBND thành phố Hải Phòng
FierceBiotech
Lilly reneges on remainder of Rigel deal in another blow for RIPK1 inhibitors
Thermo Fisher
Thermo Fisher (TMO) Q4 2024 Earnings Transcript - AOL.com
Waters
WAT (Waters Corporation) rises 1.06 percent after Q4 2025 results, as 7 percent revenue growth offsets minor EPS miss. - Earnings Risk - Cổng thông tin điện tử Tỉnh Sơn La
FierceBiotech
McKesson swaps minority stake in surgical unit to Apollo Funds for $1.25B
FierceBiotech
AcuityMD raises $80M to help bolster AI in the medtech industry
FierceBiotech
AACR: NCI leader Letai battles ‘misinformation’ to assure anxious researchers that ‘funding is strong’
FierceBiotech
Merck goes with Google for AI push, striking enterprise partnership worth up to $1B
BioWorld
Appointments and advancements for April 22, 2026
BioWorld
Financings for April 22, 2026
BioWorld
In the clinic for April 22, 2026
BioWorld
Other news to note for April 22, 2026
Archives
Rechercher
Rechercher
Récent
Plus ancien
Effacer
@BioWorld
Total
1071
Source
BioWorld
Recherche
--
BioWorld
9 févr. 2026
Appointments and advancements for Feb. 9, 2026
BioWorld
9 févr. 2026
Financings for Feb. 9, 2026
BioWorld
9 févr. 2026
In the clinic for Feb. 9, 2026
BioWorld
9 févr. 2026
Other news to note for Feb. 9, 2026
BioWorld
9 févr. 2026
Regulatory actions for Feb. 9, 2026
BioWorld
9 févr. 2026
Innovent-Lilly $8.5B deal signals new China inflection point
BioWorld
9 févr. 2026
Biggest gainers and losers for Feb. 2-6, 2026
BioWorld
9 févr. 2026
Venenum Biodesign discloses new MOGAT2 inhibitors
BioWorld
9 févr. 2026
Korean researchers report new HER1/HER2 mutant inhibitors
BioWorld
9 févr. 2026
Hansoh Pharma and Hansoh Bio synthesize new muscarinic M4 receptor agonists
BioWorld
6 févr. 2026
Idorsia gets FDA-backed route to approval for oral Fabry drug
BioWorld
6 févr. 2026
More biopharma IPOs: Agomab raises $200M, Spyglass gets $150M
BioWorld
6 févr. 2026
Bayer’s asundexian cuts stroke risk 26% in phase III win
BioWorld
6 févr. 2026
Money raised by biopharma
BioWorld
6 févr. 2026
Biopharma money raised: Jan. 1-Feb. 5, 2026
BioWorld
6 févr. 2026
BioWorld and Nasdaq stock indices
BioWorld
6 févr. 2026
Biopharma money raised by month in 2026 (US$M)
BioWorld
6 févr. 2026
Trump’s drug-discount website goes live
Précédent
30 / 60
Suivant